Peer Review History
| Original SubmissionJune 30, 2021 |
|---|
|
PONE-D-21-21414Attitude and perception of health professionals towards COVID-19 vaccination and associated factors among health professionals found in Health facilities of Nekemte town, Western EthiopiaPLOS ONE Dear Dr. Tolossa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated by two reviewers, and their comments are available below. Further comments to address are also included in the attached files and these need to be fully addressed. The reviewers have raised a number of major concerns. They request improvements to the reporting of methodological aspects of the study, for example, providing more information on the tool used for data collection, the sample size calculation, and ensuring that the manuscript follows STROBE guidelines. In addition, the reviewers also note concerns about the quality of the written English and request that assistance is sought by a native English speaker with experience in scientific writing. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Feb 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, James Mockridge Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter - please provide the reference number for the ethical approval clearance - please provide a completed STROBE checklist as an 'Other' file when resubmitting (see https://www.strobe-statement.org/checklists/) - please clarify why verbal consent was provided and not written informed consent. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Author, I have some comments and corrections. I added an MS Word file. You should edit your manuscript with STROBE guideline. You should give exact values in the result section. You should checked your manuscript for typos. Best wishes Reviewer #2: Generally, there are lots of grammar issues, incohherence of writting methods and results,as a result unrserved effort is recommended to the authors to in crease the quality of the man uscript. All the comments are easily readable with Foxit reader in the manuscript. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-21-21414R1Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western EthiopiaPLOS ONE Dear Dr. Tolossa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. TITLE: Please add the study design in the title, as per the STROBE Guidelines. You might like to revise the title as follows: ‘Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals in Western Ethiopia: a cross sectional survey’ ABSTRACT: Introduction:
Results:
Conclusion:
INTRODUCTION:
METHODS:
Software:
Ethics:
RESULTS
DISCUSSION
REFERNCES:
Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Syed Ghulam Sarwar Shah, M.B.B.S., M.A., M.Sc., Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please address the following issues. TITLE: Please add the study design in the title, as per the STROBE Guidelines. You might like to revise the title as follows: ‘Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals in Western Ethiopia: a cross sectional survey’ ABSTRACT: Introduction: 1. Please delete ‘the’ before towards in this sentence: “…..health professionals the towards the COVID 19 vaccine in resource-limited settings like Ethiopia.” 2. Please change ‘Hence, this study aimed’ to ‘The aim of study was’ in the following sentence: “Hence, this study aimed to assess health professionals' attitudes and perceptions towards COVID 19 vaccine in West Ethiopia.” 3. The authors have written ‘Western Ethiopia’ in the title and ‘West Ethiopia’ in the abstract. Please keep the same terminology in the whole manuscript so revise the text thoroughly. Results: 4. Please delete ‘were’ in this sentence: “A total of 431 health professionals were participated…..”. 5. Please change from: ‘The study indicates that…” to ‘The results indicated that..’ 6. Please report p values in the abstract. Conclusion: 7. The following statement is not included and supported by the results hence it could be removed: “Therefore, there is still a need to improve health professionals' knowledge of the COVID-19 vaccine by providing reliable information regarding vaccine safety, efficacy, and effectiveness.” INTRODUCTION: 8. Please delete ‘and’ before ‘the’ in this sentence “…., and the COVID-19…’ 9. Please delete either ‘coronavirus’ or ‘COVID-19’from this sentence: “According to the worldometer report, the coronavirus COVID-19…”. 10. Please revise this sentence: “More than 170 million cases, and 3.5 million deaths happened due to COVID-19 [1, 2].” as “More than 170 million cases, and 3.5 million deaths have happened due to COVID-19, as of (add date/month/year) [1, 2]. 11. Please delete ‘health care system challenges;, which is given twice in this sentence: “The pandemic brought the double burden in developing countries already overwhelmed by the health care system challenges already overwhelmed by the health care system challenges [3].” 12. The following information has become old so it could be omitted and you can name a few COVID vaccines that are being used globally or locally. “Many vaccines started to arise around 2020; there are hundreds of candidate vaccines [7]. As of June 10, 2021, from 287 candidate vaccines, 102 are in the clinical phase, 185 are in the preclinical phase [8]. From these, WHO has listed the Pfizer/BioNTech, Astrazeneca-SK Bio,Serum Institute of India, Janssen and Moderna vaccines for emergency use [6, 7]. 13. Please delete ‘hope of’ from this sentence: Even though people of the world were eagerly waiting for the hope of vaccine development…” 14. Please delete ‘A’ before ‘studies’ in the following sentence: “A studies conducted in different regions of Ethiopia, ….” 15. Please revise “Several evidence indicates’ to ‘Several studies indicate’…. 16. Please delete ‘now’ in this sentence: “…..9651 deaths till now, May 30, 2021 [1].” METHODS: 17. Please change ‘found’ to ‘located’ in this sentence: “This study was conducted in health institutions found in Nekemte town.” 18. Please add a full stop / period (.) at the end of this sentence: More than 800 health professionals are found in Nekemte town 19. Sample size: please double check the sample size with15% non-response, as my calculation is a little higher than 439 reported. 20. Please report who was included/considered as ‘health professionals’. Was it every body working in hospitals or only doctors, nurses and AHPs. 21. Variable mean: The authors report that items were measured on 5 point Likert scale and “Attitude was takes as “favorable” when the overall score was greater than or equal to the mean and less than mean value was rated as an "unfavorable attitude" towards COVID-19 vaccine.” Could you please what were scores for each point of the scale and what was the mean value of the scale scores. 22. Could you please either refer to relevant table or report 10 items used to measure the attitude and report whether these items were adapted from an earlier survey or developed at home. Please report sources if adapted. 23. Please either refer to relevant table or report 5 items used to assess the knowledge of health professionals towards the COVID-19 vaccine. Also, report whether these items were adapted from an earlier survey or developed at home. Please report sources if adapted. 24. Please either refer to relevant table or report 5 items used to measure the perception and report whether these items were adapted from an earlier survey or developed at home. Please report sources if adapted. Could you also report how yes or no were scored. 25. There is repetition of reporting language in which questionnaire was developed. “The tool was designed and distributed to respondents in English language…”. AND “The questionnaire was prepared in English,..”. Please avoid repetition and revise the text. 26. Please report the acceptable level of Cronbach’s alpha in the following sentence: “Cronbach’s alpha was used to assess the reliability of the tool.” 27. Please refer questionnaire included as supplementary material. Software: 28. Software: please report citations and references for Epidata and STATA software used. Ethics: 29. Please report the data and number of ethics approval by the Ethics Review Board. RESULTS 30. In the methods section it is reported that the questionnaire was given to health professionals for self- completion while the results section reports that the health professionals were interviewed. Please provide the correct information about how and who completed the questionnaires Either respondents or researchers or both. 31. You might like to delete ‘Again in this study’ in this sentence: “Again in this study, greater than half of the participants were vaccinated against coronavirus 240 (55.68%).” 32. You might like to remove ‘In this study’ from this sentence: “In this study, almost half 210 (48.72 %) of the participants have poor attitude toward COVID-19 vaccination.” 33. Please change ‘discovered’ to ‘developed’ in the following sentence: “Regarding the effectiveness of the newly discovered COVID-19 vaccination,..” 34. Table 3: please check the number of respondents for item 3 “Do you think that covid vaccine is mandatory for health care workers?” because the total number is higher than 341 (Yes 262, 60.79%, No 262, 60.79% and I don’t know 145, 33.64%. 35. Please double check data (counts and %) in all tables. DISCUSSION 36. Please revise/change ‘Works of literature are reporting as vaccine..” to ‘Literature shows that as vaccine… 37. Please change ‘the worries of the peoples’ to ‘the worries of the people…” 38. Please avoid reporting results in the discussion section like ‘AOR=0.38(95%CI: 0.22, 0.64)).’ REFERENCES: 39. Please report abbreviations of journal names as reported in the PubMed, if available. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Author, Thank you for all corrections. I do not have an additional recommendation. It is publishable work for me. Best wishes Reviewer #2: the title of figure 2;"is the corna virus vaccine has side effects?" must be wirriten in better way ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: a cross-sectional survey PONE-D-21-21414R2 Dear Dr. Tolossa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Syed Ghulam Sarwar Shah, M.B.B.S., M.A., M.Sc., Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): The authors need to report journal names in their abbreviated form, which was suggested by the Academic editor in his last report. There are similar articles from the same region of the same country i.e. Ethiopia. Possible duplication or plagiarism may be checked before the acceptance decision is conveyed to the authors. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-21414R2 Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: a cross-sectional survey Dear Dr. Tolossa: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Syed Ghulam Sarwar Shah Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .